Web Analytics




Home Tags Posts tagged with "Fu Wei"

Tag: Fu Wei

Deal digest

China’s YishengBio eyes US capital markets via SPAC route

Yisheng Biopharma has abandoned its Hong Kong IPO and turned instead to the Nasdaq via the SPAC route in a deal that is expected to be sealed by the first quarter of 2023

0

LATEST ON LAW.ASIA

MOST READ ON LAW.ASIA

Tahota Law Firm's Hefei office

Tahota secures approval to open Hefei office in October

Legal guide to doing business in the Philippines

By John Maynard Atotubo, Minerva Santos and Roberto Santiago Jr, PunoLaw

IBLJ Law Firm Awards, 2026

Setting the benchmark for legal excellence in India

McAfee Dark Pattern Penalty

India’s CCPA fines McAfee over violation of consumer rights

JX Advanced Metals Convertible Bonds

Nishimura & Asahi, Clifford Chance drive USD1.5bn bond offering

MGA Insurance Rules

IFSCA introduces managing general agents for foreign insurers

Correspondents

Arbitration Clause Drafting

Consent, clarity and arbitration clause lessons

By Hiral Gupta and Surabhi Sharan, Bharucha & Partners
India Green Channel Route

Green Channel Route: Gains and predictability

By Vandana Pai and Hardik Dave, Bharucha & Partners
Impact Investing Compliancevideo

Impact investing: Do use of proceeds clauses actually work?

By Mita Sood, Bharucha & Partners
Arbitration Due Process Limitsvideo

Policy, process and delay in arbitral challenges

By Sneha Jaisingh and Jaidhara Shah, Bharucha & Partners
Follow Law.asia
Law firms Awards Events Legal jobs • Post a job
About us Archive Subscribe Contact us
Please send any press releases, deal announcements, details of new hires, newsletters and any other news items to: news@law.asia
© Copyright 2026 Law.asia Limited. All rights reserved.

Follow us on LinkedIn

Follow now